Dietary dilemmas in the management of glycogen storage disease type I

Journal of Inherited Metabolic Disease

Volumn 34, Issue 3, 2011, Pages 621-629

  Bhattacharya, Kaustuv ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ESSENTIAL FATTY ACID; FATTY ACID DERIVATIVE; MEDIUM CHAIN TRIACYLGLYCEROL; SUGAR; TRACE ELEMENT;

CALORIC INTAKE; CARBOHYDRATE INTAKE; CHILD NUTRITION; CONFERENCE PAPER; DIET SUPPLEMENTATION; DIET THERAPY; DIETARY INTAKE; FAT INTAKE; FEEDING BEHAVIOR; FOOD COMPOSITION; FOOD QUALITY; GLYCEMIC INDEX; GLYCOGEN STORAGE DISEASE TYPE 1; HEALTH EDUCATION; HEALTH HAZARD; HUMAN; HYPERINSULINEMIA; HYPOGLYCEMIA; MACRONUTRIENT; METABOLIC REGULATION; NUTRITIONAL HEALTH; NUTRITIONAL REQUIREMENT; NUTRITIONAL VALUE; OBESITY; PATIENT EDUCATION; PROTEIN INTAKE;

ADULT; DIET; DIETARY CARBOHYDRATES; DIETARY FATS; DISSENT AND DISPUTES; ENERGY INTAKE; GLYCOGEN STORAGE DISEASE TYPE I; HUMANS; SOCIAL CHANGE;

EID: 79959773635     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-011-9322-8     Document Type: Conference Paper

References (50)

1. Baker L, Dahlem S, Goldfarb S et al. (1989) Hyperfiltration and renal disease in glycogen storage disease, type I. Kidney Int 35(6):1345-1350 (Pubitemid 19167927)
2. Bandsma RH, Smit GP, Reijngoud DJ, Kuipers F (2009) Adiponectin levels correlate with the severity of hypertriglyceridaemia in glycogen storage disease Ia. J Inherit Metab Dis
3. Banugaria SG, Austin SL, Boney A, Weber TJ, Kishnani PS (2010) Hypovitaminosis D in glycogen storage disease type I. Mol Genet Metab 99(4):434-437
4. Bernier AV, Correia CE, Haller MJ, Theriaque DW, Shuster JJ, Weinstein DA (2009) Vascular dysfunction in glycogen storage disease type I. J Pediatr 154(4):588-591
5. Bhattacharya K, Orton RC, Qi E et al. (2007) A novel starch for the treatment of glycogen storage diseases. J Inherit Metab Dis 30(3):350-357 (Pubitemid 46881681)
6. Bier DM, Leake RD, Haymond MW et al. (1977) Measurement of "true" glucose production rates in infancy and childhood with 6,6-dideuteroglucose. Diabetes 26(11):1016-1023
7. Bodamer OA, Feillet F, Lane RE et al. (2002) Utilization of cornstarch in glycogen storage disease type Ia. Eur J Gastroenterol Hepatol 14(11):1251-1256 (Pubitemid 35476880)
8. Bonnefont JP, Specola NB, Vassault A et al. (1990) The fasting test in paediatrics: application to the diagnosis of pathological hypoand hyperketotic states. Eur J Pediatr 150(2):80-85
9. Chen YT (2001) Glycogen storage diseases. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 1521-1551
10. Chen YT, Cornblath M, Sidbury JB (1984) Cornstarch therapy in type I glycogen-storage disease. N Engl J Med 310(3):171-175 (Pubitemid 14224111)
11. Chen YT, Bazzarre CH, Lee MM, Sidbury JB, Coleman RA (1993) Type I glycogen storage disease: nine years of management with cornstarch. Eur J Pediatr 152(Suppl 1):S56-S59 (Pubitemid 23134780)
12. Collins JE, Bartlett K, Leonard JV, Aynsley-Green A et al. (1990) Glucose production rates in type 1 glycogen storage disease. J Inherit Metab Dis 13(2):195-206 (Pubitemid 20227092)
13. Correia C, Bhattacharya K, Shuster JJ et al. (2008) Use of modified cornstarch therapy to extend fasting in glycogen storage disease types Ia and Ib. Am J Clin Nutr
14. Das AM, Lucke T, Meyer U, Hartmann H, Illsinger S (2010) Glycogen storage disease type 1: impact of medium-chain triglycerides on metabolic control and growth. Ann Nutr Metab 56(3):225-232
15. Daublin G, Schwahn B, Wendel U (2002) Type I glycogen storage disease: favourable outcome on a strict management regimen avoiding increased lactate production during childhood and adolescence. Eur J Pediatr 161(Suppl 1):S40-S45
16. den Hollander NC, Mulder DJ, Graaff R et al. (2007) Advanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia. J Inherit Metab Dis 30(6):916-923 (Pubitemid 350263132)
17. Department of Health. Report on, H. and S. Social (1991) Dietary reference values for food energy and nutrients for the United Kingdom. London HMSO
18. Dixon MA (2007) In: Shaw V, Lawson M (eds) Glycogen storage diseases. Clinical paediatric dietetics. Blackwell Sciences Ltd, Oxford, pp 390-400
19. Fernandes J (1974) The effect of disaccharides on the hyperlactacidaemia of glucose-6-phosphatase-deficient children. Acta Paediatr Scand 63(5):695-698
20. Fernandes J, Berger R, Smit GP (1984) Lactate as a cerebral metabolic fuel for glucose-6-phosphatase deficient children. Pediatr Res 18(4):335-339 (Pubitemid 14134221)
21. Fernandes J, Pikaar NA (1969) Hyperlipemia in children with liver glycogen disease. Am J Clin Nutr 22(5):617-627
22. Fernandes J, Pikaar NA (1972) Ketosis in hepatic glycogenosis. Arch Dis Child 47(251):41-46
23. Fernandes J, Van De Kamer JH (1965) Studies on the utilization of hexoses in liver glycogen storage disease. Pediatrics 35:470-477
24. Food Standards Agency (2008) McCance and Widdowson's the composition of foods. Royal Society of Chemistry, Cambridge
25. Ghosh A, Cheung YY, Mansfield BC, Chou JY (2005) Brain contains a functional glucose-6-phosphatase complex capable of endogenous glucose production. J Biol Chem 280(12):11114-11119 (Pubitemid 40418416)
26. Goldberg T, Slonim AE (1993) Nutrition therapy for hepatic glycogen storage diseases. J Am Diet Assoc 93(12):1423-1430 (Pubitemid 24002885)
27. Goulart JM, Yoo JY, Kirchoff-Torres KF, Delman BN, Tuhrim S (2010) Ischemic stroke in an adult with glycogen storage disease type I. J Clin Neurosci 17(11):1467-1469
28. Gregory J, Lowe S (2000) National diet and nutrition survey: young people aged 4 to 18 years. The Stationary Office, London
29. Hoare J, Henderson L, Bates CJ et al. (2004) National diet and nutrition survey: adults aged 19 to 64 years, 2000-2001. The Office for National Statistics. Social and Vital Statistics Division and Food Standards Agency, Colchester
30. Kishnani PS, Boney A, Chen YT (1999) Nutritional deficiencies in a patient with glycogen storage disease type Ib. J Inherit Metab Dis 22(7):795-801 (Pubitemid 29429936)
31. Lee PJ, Celermajer DS, Robinson J et al. (1994) Hyperlipidaemia does not impair vascular endothelial function in glycogen storage disease type 1a. Atherosclerosis 110(1):95-100 (Pubitemid 24312432)
32. Lee PJ, Dalton RN, Shah V, Hindmarsh PC, Leonard JV (1995a) Glomerular and tubular function in glycogen storage disease. Pediatr Nephrol 9(6):705-710 (Pubitemid 26003671)
33. Lee PJ, Leonard JV (1995) The hepatic glycogen storage diseases - problems beyond childhood. J Inherit Metab Dis 18(4):462-472
34. Lee PJ, Patel JS, Fewtrell M, Leonard JV, Bishop NJ (1995b) Bone mineralisation in type 1 glycogen storage disease. Eur J Pediatr 154(6):483-487
35. Levy E, Thibault L, Turgeon J et al. (1993) Beneficial effects of fish-oil supplements on lipids, lipoproteins, and lipoprotein lipase in patients with glycogen storage disease type I. Am J Clin Nutr 57(6):922-929 (Pubitemid 23156717)
36. Morris AA, Thekekara A, Wilks Z, Clayton PT, Leonard JV, Aynsley-Green A (1996) Evaluation of fasts for investigating hypoglycaemia or suspected metabolic disease. Arch Dis Child 75(2):115-119 (Pubitemid 26276150)
37. Muhlhausen C, Schneppenheim R, Budde U et al. (2005) Decreased plasma concentration of von Willebrand factor antigen (VWF: Ag) in patients with glycogen storage disease type Ia. J Inherit Metab Dis 28(6):945-950 (Pubitemid 43168931)
38. Nagasaka H, Hirano K, Ohtake A et al. (2007) Improvements of hypertriglyceridemia and hyperlacticemia in Japanese children with glycogen storage disease type Ia bymedium-chain triglyceride milk. Eur J Pediatr 166(10):1009-1016 (Pubitemid 47313064)
39. Rake J, Visser G, Labrune P, Leonard J, Ullrich K, Smit G (2002a) Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European study on glycogen storage disease type I (ESGSD I). Eur J Pediatr 161(1):S20-S34
40. Rake J, Visser G, Labrune P, Leonard J, Ullrich K, Smit G (2002b) Guidelines for management of glycogen storage disease type I - European study on glycogen storage disease type I (ESGSD I). Eur J Pediatr 161(1):S112-S119
41. Santer R, Hillebrand G, Steinmann B, Schaub J (2003) Intestinal glucose transport: evidence for a membrane traffic-based pathway in humans. Gastroenterology 124(1):34-39 (Pubitemid 36055336)
42. Schwenk WF, Haymond MW (1986) Optimal rate of enteral glucose administration in children with glycogen storage disease type I. N Engl J Med 314(11):682-685 (Pubitemid 16164098)
43. Shieh JJ, Pan CJ, Mansfield BC, Chou JY (2003) A glucose-6-phosphate hydrolase, widely expressed outside the liver, can explain age-dependent resolution of hypoglycemia in glycogen storage disease type Ia. J Biol Chem 278(47):47098-47103 (Pubitemid 37452295)
44. Smit GP, Berger R, Potasnick R, Moses SW, Fernandes J (1984) The dietary treatment of children with type I glycogen storage disease with slow release carbohydrate. Pediatr Res 18(9):879-881 (Pubitemid 14072419)
45. Spiegel R, Rakover-Tenenbaum Y, Mandel H, Lumelski D, Admoni O, Horovitz Y (2005) Secondary diabetesmellitus: late complication of glycogen storage disease type 1b. J Pediatr Endocrinol Metab 18(6):617-619 (Pubitemid 40916493)
46. Storch E, Keeley M, Merlo L, Jacob M, Correia C, Weinstein D (2008) Psychosocial functioning in youth with glycogen storage disease type I. J Pediatr Psychol
47. Visser G, Rake JP, Kokke FT, Nikkels PG, Sauer PJ, Smit GP (2002) Intestinal function in glycogen storage disease type I. J Inherit Metab Dis 25(4):261-267 (Pubitemid 34982058)
48. Weinstein D, Wolfsdorf J (2002) Effect of continuous glucose therapy with uncooked cornstarch on the long-term clinical course of type 1a glycogen storage disease. Eur J Pediatr 161:S35-S39
49. Wolfsdorf JI, Ehrlich S, Landy HS, Crigler JF (1992) Optimal daytime feeding regimen to prevent postprandial hypoglycemia in type 1 glycogen storage disease. Am J Clin Nutr 56(3):587-592
50. Yekeler E, Dursun M, Emeksiz E et al. (2007) Prediction of premature atherosclerosis by endothelial dysfunction and increased intimamedia thickness in glycogen storage disease types Ia and III. Turk J Pediatr 49(2):115-119 (Pubitemid 47299793)